SB772077B, A New Rho Kinase Inhibitor Enhances Aqueous Humour Outflow Facility in Human Eyes.

A highly significant reduction of β-catenin expression was achieved with SB77 treatment as compared to control (p = 0.000); however, it was not found to be statistically significant when compared with Y27632 (Fig. 6 ; p = 0.088).

also in 132,142 other papers